- Report
- October 2026
- 335 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 219 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 172 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 295 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 172 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 268 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 283 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 186 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 380 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 273 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 354 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 292 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 291 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 82 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 191 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 386 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 362 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 121 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 259 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 482 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more